2482-25-9 | 4-Hydroxy-Bz-Gly-OH

Packsize	Purity	Availability	Price	Discounted Price
100mg	≥98%	in stock	$48.00	$34.00
250mg	≥98%	in stock	$93.00	$65.00
1g	97%	in stock	$139.00	$97.00
5g	97%	in stock	$473.00	$331.00
10g	97%	in stock	$783.00	$548.00
25g	97%	in stock	$1,536.00	$1,075.00

Description

• Catalog Number: AB26221
• Chemical Name: 4-Hydroxy-Bz-Gly-OH
• CAS Number: 2482-25-9
• Molecular Formula: C9H9NO4
• Molecular Weight: 195.1721
• MDL Number: MFCD00237117
• SMILES: OC(=O)CNC(=O)c1ccc(cc1)O

Computed Properties

• Complexity: 221
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 3
• XLogP3: -0.6

Literature

• SPE-NMR metabolite sub-profiling of urine.

  Analytical and bioanalytical chemistry 20121101

• Stability and robustness of human metabolic phenotypes in response to sequential food challenges.

  Journal of proteome research 20120203

• Ca(2+)-Mg (2+)-dependent ATP-ase activity in hemodialyzed children. Effect of a hemodialysis session.

  Pediatric nephrology (Berlin, Germany) 20101201

• The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics.

  Molecular nutrition & food research 20100701

• Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells.

  The British journal of nutrition 20090701

• Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).

  Bioorganic & medicinal chemistry 20081201

• The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080801

• Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.

  British journal of pharmacology 20020101

• Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure.

  Kidney international. Supplement 20010201